Comprehensive In Vitro Approach To Evaluating Transporter-Mediated Drug Interactions

Comprehensive In Vitro Approach to Evaluating Transporter-mediated Drug Interactions

Eurofins Discovery

Transporter Mediated Drug-Drug Interactions: A Case Study with Dr. Jomy M. George

NIH Clinical Center

Evaluating the Kidney Chip for Transporter Mediated Drug Drug Interactions Applications

Transporter Mediated Drug-Drug Interactions: A Case Study

In Vitro Evaluation of Immunomodulating Drugs as Perpetrators of Drug Interactions

In Vitro DDI Drug Transporter Studies ADME 101 Webinar: Efflux and Uptake Transporters

ADME 101: Overview of In Vitro Drug-Drug Interaction (DDI) Studies

BioIVT: Trusted Biospecimen Provider

PSPG Seminar: Regulatory Science on Transporter-Mediated Drug-Drug Interactions

UCSF-Stanford CERSI

In Vitro ADME & Drug-Drug Interaction Considerations for Toxicologists

Understanding P-gp and BCRP Inhibition Assay Design and Outcomes

The Important Role of UDP Glucuronosyltransferases in Drug Metabolism and Drug Drug Interactions

Are In Vitro Metabolism and DDI Studies Critical for an Investigational New Drug Application?

InsideScientific

Drug Transporters in ADME and Drug Action with Dr. Joseph Ware

NIH Clinical Center

Drug Transporter Webinar: Evaluation of Ketoconazole & Alt. Clinical CYP3A4-5 Inhibitors

Role of Sulfotransferases in Drug Metabolism and Potential for Drug Drug Interactions

PET imaging and pharmacokinetic modelling of hepatobiliary Transporters

Auckland Bioengineering Institute

Recent Advances in Transporter Testing Strategies...

Eurofins Discovery

Highlights of the In Vitro Sections of the 2022 Draft ICH Drug Interaction Studies Guideline...

Model-Based Approaches to DDI Risk Prediction-Transitioning from In Vitro Data to In Silico Modeling

Updates on FDA’s Drug-Drug Interaction Final Guidances

U.S. Food and Drug Administration